Texas Biomed SOW accelerates pivotal FDA pathway
Filed with ASX · · 6 pages · English
Island Pharmaceuticals Ltd on 6ix
Earlier from Island Pharmaceuticals
- Investor Presentation - Ebola Clinical Program
- Galidesivir approved for treatment use in in Ebola epidemic
- Pause in Trading
- Singapore Patent Expands Island's ISLA 101 Viral Protection
- FDA Grants Orphan Designation for Galidesivir in Marburg
Later from Island Pharmaceuticals
- Quarterly Appendix 4C and Activities Report
- Investor presentation
- Application for quotation of securities - ILA
- Cleansing Notice
- Date of AGM & Closing Date for Director Nominations
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals